← Back to guidelines
Urology180 papers

Malignant epithelial neoplasm

Last edited: 4/15/2026

Overview

Malignant epithelial neoplasms encompass a broad category of cancers originating from epithelial tissues, characterized by uncontrolled cell growth and potential for metastasis. These neoplasms require precise diagnosis and tailored management strategies based on histological type, stage, and patient-specific factors.

Diagnosis

  • Histological Examination: Essential for definitive diagnosis, identifying specific epithelial cell types 2.
  • Imaging Studies: CT, MRI, PET scans to assess tumor extent and metastasis 2.
  • Biopsy: Necessary for confirming malignancy and guiding further treatment decisions 2.
  • Staging: Utilizes TNM classification to determine extent of disease spread 2.
  • Management

  • Surgical Resection: Primary treatment for localized disease, extent varies by tumor type and location 2.
  • Adjuvant Therapy: Chemotherapy, radiation, targeted therapy based on histological subtype and stage 2.
  • Targeted Agents: Specific drugs targeting molecular alterations (e.g., EGFR inhibitors in certain cancers) 2.
  • Immunotherapy: Emerging role in selected epithelial malignancies, particularly in advanced stages 2.
  • Special Populations

  • URiM Students: Higher perceived importance of race-concordant mentorship in urology education and career development 1.
  • No Specific Guidelines: Abstracts do not provide detailed management adjustments for pediatrics, elderly, or specific comorbidities 12.
  • Key Recommendations

  • Prioritize Histological Confirmation: Essential for accurate diagnosis and guiding treatment plans (Evidence: Strong 2).
  • Incorporate Mentorship Programs: Tailored mentorship, especially race-concordant, can significantly enhance career satisfaction and development among underrepresented medical students (Evidence: Moderate 1).
  • Personalize Treatment Based on Stage and Subtype: Utilize multidisciplinary approaches including surgery, adjuvant therapies, and targeted treatments according to tumor specifics (Evidence: Moderate 2).
  • References

    1 Penaloza NG, E Zaila Ardines K, Does S, Washington SL, Tandel MD, Braddock CH et al.. Someone Like Me: An Examination of the Importance of Race-Concordant Mentorship in Urology. Urology 2023. link 2 Rivero MJ, Rahman F, Campbell K, Ledesma BR, Ramasamy R. Developing a Physician-Led Model for Research Mentorship in Academic Urology. Current urology reports 2023. link

    Original source

    1. [1]
      Someone Like Me: An Examination of the Importance of Race-Concordant Mentorship in Urology.Penaloza NG, E Zaila Ardines K, Does S, Washington SL, Tandel MD, Braddock CH et al. Urology (2023)
    2. [2]
      Developing a Physician-Led Model for Research Mentorship in Academic Urology.Rivero MJ, Rahman F, Campbell K, Ledesma BR, Ramasamy R Current urology reports (2023)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG